deltatrials
Recruiting NA INTERVENTIONAL 2-arm NCT05844384

Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial

Sponsor: 59th Medical Wing

Conditions Ocular Hypertension Primary Open Angle Glaucoma
Interventions Nanodropper Regular dropper
Updated 5 times since 2023 Last updated: May 3, 2023 Started: Mar 17, 2022 Primary completion: Mar 17, 2024 Completion: Mar 17, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Ocular Hypertension and Primary Open Angle Glaucoma and is currently actively recruiting participants. 59th Medical Wing leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Jun 2023 – ~Jul 2024 · 13 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~May 2025 · 8 months · monthly snapshotRecruiting~May 2025 – ~Sep 2025 · 4 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotRecruiting

Change History

5 versions recorded

  1. Sep 2025 — Present [monthly]

    Recruiting NA

    Status: Unknown → Recruiting

  2. May 2025 — Sep 2025 [monthly]

    Unknown NA

    Status: Recruiting → Unknown

  3. Sep 2024 — May 2025 [monthly]

    Recruiting NA

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  5. Jun 2023 — Jul 2024 [monthly]

    Recruiting NA

    First recorded

Mar 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • 59th Medical Wing
  • Nanodropper, Inc.
Data source: 59th Medical Wing

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations